Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2025-12-27 @ 9:53 PM
Study NCT ID:
NCT05619861
Status:
UNKNOWN
Last Update Posted:
2022-11-17
First Post:
2022-11-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CAR-T Cells in the Treatment of Malignant Hematological Tumors
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-26
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-09
First Submit QC Date:
None
Study First Post Date:
2022-11-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-09
Last Update Post Date:
2022-11-17
Last Update Post Date Type:
ACTUAL